Delivery Order SPE2DB24D2010-SPE2DB25FAAVU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8S, a migraine treatment medication, valued at $31,592.78 under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,444.01 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 MG, a medication used to treat acute migraine. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract utilizes a non-set-aside procurement vehicle and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $20,789.88 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg, a migraine treatment medication. The contract was competitively awarded without set-aside status on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed-price structure, typical of the agency's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $40,456.88 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg, a migraine treatment medication. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract carries no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,213.10 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $8,833.84 under a firm fixed price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,145.63 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG Tablet 8s, a migraine treatment medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $21,080.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAVUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,329.70 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG Tablet 8s, a prescription medication used to treat acute migraines. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract specifies performance at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under a larger indefinite delivery vehicle. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor specializing in pharmaceutical and medical supply distribution to defense and veteran healthcare systems. The DLA's pharmaceutical procurement through this prime vendor arrangement enables efficient delivery of brand-name and generic medications across multiple therapeutic domains to support the Defense Health Agency and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 8/15/25 |